Australia markets closed
  • ALL ORDS

    6,865.30
    +18.00 (+0.26%)
     
  • ASX 200

    6,634.10
    +18.80 (+0.28%)
     
  • AUD/USD

    0.7431
    -0.0008 (-0.11%)
     
  • OIL

    45.98
    +0.34 (+0.74%)
     
  • GOLD

    1,837.20
    -3.90 (-0.21%)
     
  • BTC-AUD

    25,565.41
    -331.70 (-1.28%)
     
  • CMC Crypto 200

    372.50
    -6.74 (-1.78%)
     
  • AUD/EUR

    0.6114
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0546
    +0.0035 (+0.34%)
     
  • NZX 50

    12,631.38
    -17.53 (-0.14%)
     
  • NASDAQ

    12,476.18
    +9.05 (+0.07%)
     
  • FTSE

    6,549.43
    +59.16 (+0.91%)
     
  • Dow Jones

    30,103.96
    +134.44 (+0.45%)
     
  • DAX

    13,277.33
    +24.47 (+0.18%)
     
  • Hang Seng

    26,835.92
    +107.42 (+0.40%)
     
  • NIKKEI 225

    26,751.24
    -58.13 (-0.22%)
     

Cell Line Development Market Research Report by Type, by Sera, by Reagents, by Media, by Source, by Equipment, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Cell Line Development Market Research Report by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines, and Recombinant Cell Lines), by Sera (Adult Bovine Sera and Fetal Bovine Sera), by Reagents, by Media, by Source, by Equipment, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Line Development Market Research Report by Type, by Sera, by Reagents, by Media, by Source, by Equipment, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913777/?utm_source=GNW

The Global Cell Line Development Market is expected to grow from USD 3,407.98 Million in 2019 to USD 6,104.60 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 10.20%.

Market Segmentation & Coverage:
This research report categorizes the Cell Line Development to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Cell Line Development Market studied across Continuous Cell Lines, Hybridomas, Primary Cell Lines, and Recombinant Cell Lines.

Based on Sera, the Cell Line Development Market studied across Adult Bovine Sera and Fetal Bovine Sera.

Based on Reagents, the Cell Line Development Market studied across Buffers & Chemicals, Cell Dissociation Reagents, Cryopreservative Reagents, and Supplements & Growth Factors.

Based on Media, the Cell Line Development Market studied across Minimum Essential Media, Reduced Serum Media, and Serum-Free Media.

Based on Source, the Cell Line Development Market studied across Amphibian, Insect, and Mammalian.

Based on Equipment, the Cell Line Development Market studied across Automation Systems, Bioreactors, Biosafety Cabinets, Cell Counters & Viability Analysis Systems, Centrifuges, Filtration Systems, Incubators, Microscopes, and Storage Equipment. The Storage Equipment further studied across Cryostorage Systems and Refrigerators & Freezers.

Based on Application, the Cell Line Development Market studied across Bioproduction, Drug Discovery, Research, Tissue Engineering & Regenerative Medicine, and Toxicity Testing. The Bioproduction further studied across Diagnostics, Recombinant Protein Therapeutics, and Vaccine Production. The Drug Discovery further studied across Disease Modeling, Drug Screening and Development, and Target Validation.

Based on Geography, the Cell Line Development Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Line Development Market including American Type Culture Collection, Aragen Bioscience, Corning, Inc., Eubiologics CO., LTD., European Collection of Cell Cultures, Gallus Biopharmaceuticals, GE Healthcare, Lonza Group AG, Paragon Bioservices, Inc., Public Health England, Samsung Biologics, Sartorius AG, Selexis SA, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Vista Biologicals Corporation, and Wuxi Apptec.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Line Development Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Cell Line Development Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Line Development Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Line Development Market?
4. What is the competitive strategic window for opportunities in the Global Cell Line Development Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Line Development Market?
6. What are the modes and strategic moves considered suitable for entering the Global Cell Line Development Market?
Read the full report: https://www.reportlinker.com/p05913777/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001